Loading clinical trials...
Loading clinical trials...
24-Hour Ambulatory Blood Pressure Monitoring Study in Hypogonadal Men Receiving Testosterone Replacement Therapy
Conditions
Interventions
AndroGel 1.62%
Locations
45
United States
G & L Research, LLC /ID# 216793
Foley, Alabama, United States
NewportNativeMD, Inc. /ID# 216992
Newport Beach, California, United States
Valley Renal Medical Group Research /ID# 216321
Northridge, California, United States
West Coast Research LLC /ID# 216813
San Ramon, California, United States
Lynn Institute of Denver /ID# 216863
Aurora, Colorado, United States
Innovative Research of West Florida /ID# 216364
Clearwater, Florida, United States
Start Date
May 12, 2020
Primary Completion Date
December 7, 2021
Completion Date
January 7, 2022
Last Updated
December 15, 2022
NCT07546435
NCT06019182
NCT06689085
NCT06583408
NCT06841328
NCT03851627
Lead Sponsor
AbbVie
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions